Follow
Jöri Wehrmüller
Jöri Wehrmüller
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Unlocking reactivity of TrpB: a general biocatalytic platform for synthesis of tryptophan analogues
DK Romney, J Murciano-Calles, JE Wehrmüller, FH Arnold
Journal of the American Chemical Society 139 (31), 10769-10776, 2017
1162017
Dual, Site‐Specific Modification of Antibodies by Using Solid‐Phase Immobilized Microbial Transglutaminase
PR Spycher, CA Amann, JE Wehrmüller, DR Hurwitz, O Kreis, D Messmer, ...
ChemBioChem 18 (19), 1923-1927, 2017
592017
Abstract LB-106: Overcoming limitations of current Antibody-Drug Conjugates (ADCs) by a novel linker technology
PR Spycher, JC Frei, JE Wehrmüller, I Attinger-Toller, D Grabulovski, ...
Cancer Research 79 (13 Supplement), LB-106-LB-106, 2019
12019
Developing stoichiometrically well-defined antibody-drug conjugates by enzymatic conjugation of native antibodies
JE Wehrmüller
ETH Zurich, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–4